Sign in
4

Changes in Ownership

GeneDx Holdings Corp. Filed Acc 0001209191-23-049135

Chief Transformation Officer sold 846 shares at $4.62 ($3,912)

  • Chief Transformation Officer acquired 2,841 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Saad Kareem Chief Transformation Officer 2023-09-09 Option exercise +2,841 15,283 D
Saad Kareem Chief Transformation Officer 2023-09-11 Sale −846 $4.62 $3,912 14,437 D
Derivatives
Saad Kareem Chief Transformation Officer 2023-09-09 Option exercise · Restricted Stock Unit −2,841 36,931 D
Open-market sales · 846 sh · avg $4.62 · $3,912
Loading xslF345X05/doc4.xml…